NS
GMAB icon

NBC Securities’s Genmab GMAB Stock Holding History

NBC Securities’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18K Sell
43
-4
-9% -$106 ﹤0.01% 2302
2026
Q1 		$1.26K Hold
47
– – ﹤0.01% 2388
2025
Q4 		$1.45K Hold
47
– – ﹤0.01% 2472
2025
Q3 		$1.44K Buy
+47
New +$1.15K ﹤0.01% 2476
2024
Q4 		– Sell
-200
Closed -$4K – 1585
2024
Q3 		$4K Hold
200
– – ﹤0.01% 1926
2024
Q2 		$5K Sell
200
-220
-52% -$6.24K ﹤0.01% 1844
2024
Q1 		$12K Sell
420
-495
-54% -$14.5K ﹤0.01% 1630
2023
Q4 		$29K Sell
915
-142
-13% -$4.46K ﹤0.01% 1314
2023
Q3 		$37K Buy
+1,057
New +$40.3K ﹤0.01% 1219

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

NBC Securities's GMAB Position: Q2 2026 in Review

NBC Securities reduced its Genmab (GMAB) stake by 8.5% in Q2 2026, selling an estimated $106 and leaving 43 shares worth $1.18K. The position accounts for ﹤0.01% of the portfolio, ranked #2302.

NBC Securities first reported a position in GMAB in Q3 2023 and has held it in 9 quarters since. The position peaked at $37K in Q3 2023. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • NBC Securities held 43 shares of Genmab worth $1.18K as of Q2 2026.
  • NBC Securities sold 4 Genmab shares in Q2 2026, an estimated $106.
  • Genmab made up ﹤0.01% of NBC Securities's portfolio in Q2 2026, its #2302 holding.
  • NBC Securities first reported a position in Genmab in Q3 2023 and has held it in 9 quarters since.
  • NBC Securities's Genmab position peaked at $37K in Q3 2023.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.